Regulatory acceptance of toxicogenomics data - PubMed (original) (raw)

Editorial

Regulatory acceptance of toxicogenomics data

Felixh W Frueh et al. Environ Health Perspect. 2004 Aug.

No abstract available

PubMed Disclaimer

Figures

Similar articles

Cited by

References

    1. FDA 2003. Draft. Guidance for Industry. Pharmacogenomic Data Submissions. Draft Guidance. Washington, DC:Food and Drug Administration. Available: www.fda.gov/cder/guidance/5900dft.pdf [accessed 26 July 2004].
    1. FDA 2004. FDA Mission Statement. 2004. Washington, DC:U.S. Food and Drug Administration. Available: http://www.fda.gov/opacom/morechoices/mission.html [accessed 26 July 2004].
    1. FDA/DIA 2004. Co-Development of Drug, Biological and Device Products, 29 July 2004, Arlington, VA. Washington, DC:U.S. Food and Drug Administration/Horsham, PA:Drug Information Association. Available: http://www.diahome.org/Content/Events/04040.pdf [accessed 26 July 2004].
    1. Leighton JK, DeGeorge J, Jacobson-Kram D, MacGregor J, Mendrick D, Worobec A. Pharmacogenomic data submissions to the FDA: non-clinical case studies . Pharmacogenomics. 2004;5(5):507–511. - PubMed
    1. Ruaño G, Collins JM, Dorner AJ, Wang S-J, Guerciolini R, Huang S-M. Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies. Pharmacogenomics. 2004;5(5):513–517. - PubMed

Publication types

MeSH terms

LinkOut - more resources